BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29293308)

  • 1. Gadolinium-Labeled Aminoglycoside and Its Potential Application as a Bacteria-Targeting Magnetic Resonance Imaging Contrast Agent.
    Zhang L; Liu Y; Zhang Q; Li T; Yang M; Yao Q; Xie X; Hu HY
    Anal Chem; 2018 Feb; 90(3):1934-1940. PubMed ID: 29293308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interplay of T1- and T2-relaxation on T1-weighted MRI of hMSCs induced by Gd-DOTA-peptides.
    Cao L; Li B; Yi P; Zhang H; Dai J; Tan B; Deng Z
    Biomaterials; 2014 Apr; 35(13):4168-74. PubMed ID: 24560458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and relaxivity studies of a tetranuclear gadolinium(III) complex of DO3A as a contrast-enhancing agent for MRI.
    Jebasingh B; Alexander V
    Inorg Chem; 2005 Dec; 44(25):9434-43. PubMed ID: 16323930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium chelate with DO3A conjugated 2-(diphenylphosphoryl)-ethyldiphenylphosphonium cation as potential tumor-selective MRI contrast agent.
    Chandrasekharan P; Yong CX; Poh Z; He T; He Z; Liu S; Robins EG; Chuang KH; Yang CT
    Biomaterials; 2012 Dec; 33(36):9225-31. PubMed ID: 23026708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasmall graphene oxide based T
    Zhang M; Liu X; Huang J; Wang L; Shen H; Luo Y; Li Z; Zhang H; Deng Z; Zhang Z
    Nanomedicine; 2018 Oct; 14(7):2475-2483. PubMed ID: 28552648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid conjugate of arabinogalactan as a potential liver-targeting magnetic resonance imaging contrast agent.
    Xiao Y; Xue R; You T; Li X; Pei F; Wang X; Lei H
    Carbohydr Res; 2014 Aug; 395():9-14. PubMed ID: 24995911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Biological Evaluation of Rhein-Based MRI Contrast Agents for in Vivo Visualization of Necrosis.
    Bian L; Gao M; Zhang D; Ji A; Su C; Duan X; Luo Q; Huang D; Feng Y; Ni Y; Yin Z; Jin Q; Zhang J
    Anal Chem; 2018 Nov; 90(22):13249-13256. PubMed ID: 30379067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclen-based Gd
    Rashid HU; Martines MAU; Jorge J; de Moraes PM; Umar MN; Khan K; Rehman HU
    Bioorg Med Chem; 2016 Nov; 24(22):5663-5684. PubMed ID: 27729196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved tumor-targeting MRI contrast agents: Gd(DOTA) conjugates of a cycloalkane-based RGD peptide.
    Park JA; Lee YJ; Ko IO; Kim TJ; Chang Y; Lim SM; Kim KM; Kim JY
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):246-50. PubMed ID: 25449282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P
    Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and performance of biocompatible gadolinium polymer as liver-targeting magnetic resonance imaging contrast agent.
    Hu T; Wan C; Zhan Y; Li X; Zheng Y
    J Biosci Bioeng; 2024 Feb; 137(2):134-140. PubMed ID: 38195341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox-sensitive biodegradable macromolecular MRI contrast agent.
    Ye Z; Zhou Z; Ayat N; Wu X; Jin E; Shi X; Lu ZR
    Contrast Media Mol Imaging; 2016; 11(1):32-40. PubMed ID: 26218648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic approaches to heterocyclic ligands for Gd-based MRI contrast agents.
    Pérez-Mayoral E; Soler-Padrós J; Negri V; Cerdán S; Ballesteros P
    Molecules; 2007 Aug; 12(8):1771-95. PubMed ID: 17960087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maltodextrin-Conjugated Gd-Based MRI Contrast Agents for Specific Diagnosis of Bacterial Infections.
    Xu C; Li Z; Akakuru OU; Pan C; Zou R; Zheng J; Wu A
    ACS Appl Bio Mater; 2021 May; 4(5):3762-3772. PubMed ID: 35006806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gd-DOTA conjugate of RGD as a potential tumor-targeting MRI contrast agent.
    Park JA; Lee JJ; Jung JC; Yu DY; Oh C; Ha S; Kim TJ; Chang Y
    Chembiochem; 2008 Nov; 9(17):2811-3. PubMed ID: 18956393
    [No Abstract]   [Full Text] [Related]  

  • 16. Alkaline Phosphatase-Instructed Self-Assembly of Gadolinium Nanofibers for Enhanced T
    Dong L; Qian J; Hai Z; Xu J; Du W; Zhong K; Liang G
    Anal Chem; 2017 Jul; 89(13):6922-6925. PubMed ID: 28627868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naphthalene-facilitated self-assembly of a Gd-chelate as a novel
    Zhang Y; Zhang H; Huang D; Tan B; Zhang C; Deng Z
    J Mater Chem B; 2021 Jul; 9(28):5729-5737. PubMed ID: 34231635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
    Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
    J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multiple gadolinium complex decorated fullerene as a highly sensitive T(1) contrast agent.
    Wang L; Zhu X; Tang X; Wu C; Zhou Z; Sun C; Deng SL; Ai H; Gao J
    Chem Commun (Camb); 2015 Mar; 51(21):4390-3. PubMed ID: 25676633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Densely packed Gd(III)-chelates with fast water exchange on a calix[4]arene scaffold: a potential MRI contrast agent.
    Schühle DT; Polásek M; Lukes I; Chauvin T; Tóth E; Schatz J; Hanefeld U; Stuart MC; Peters JA
    Dalton Trans; 2010 Jan; (1):185-91. PubMed ID: 20023949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.